Takeda Pharmaceutical Company Limited Share Price

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange 07:00:00 12/07/2024 BST 5-day change 1st Jan Change
4,298 JPY -0.32% Intraday chart for Takeda Pharmaceutical Company Limited +1.30% +6.02%

Financials

Sales 2025 * 4,289B 27.17B 2,092B Sales 2026 * 4,354B 27.58B 2,123B Capitalization 6,812B 43.15B 3,322B
Net income 2025 * 115B 727M 55.94B Net income 2026 * 216B 1.37B 105B EV / Sales 2025 * 2.55 x
Net Debt 2025 * 4,109B 26.03B 2,004B Net Debt 2026 * 3,849B 24.39B 1,877B EV / Sales 2026 * 2.45 x
P/E ratio 2025 *
59.5 x
P/E ratio 2026 *
31.6 x
Employees 49,281
Yield 2025 *
4.54%
Yield 2026 *
4.64%
Free-Float 99.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Takeda Pharmaceutical Company Limited

1 day-0.32%
1 week+1.30%
Current month+3.02%
1 month+3.19%
3 months+3.67%
6 months-0.78%
Current year+6.02%
More quotes
1 week
4 195.00
Extreme 4195
4 345.00
1 month
4 003.00
Extreme 4003
4 345.00
Current year
4 003.00
Extreme 4003
4 494.00
1 year
3 900.00
Extreme 3900
4 873.00
3 years
2 993.00
Extreme 2993
4 873.00
5 years
2 894.50
Extreme 2894.5
4 873.00
10 years
2 894.50
Extreme 2894.5
6 693.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 31/03/14
Compliance Officer 54 31/12/11
Chief Tech/Sci/R&D Officer 69 31/03/15
Members of the board TitleAgeSince
Director/Board Member 72 31/05/16
Director/Board Member 62 31/12/18
Director/Board Member 71 31/12/18
More insiders
Date Price Change Volume
12/07/24 4,298 -0.32% 3,916,000
11/07/24 4,312 +1.46% 5,195,400
10/07/24 4,250 +0.31% 4,530,000
09/07/24 4,237 +0.21% 4,000,600
08/07/24 4,228 -0.35% 3,167,400

Delayed Quote Japan Exchange, July 12, 2024 at 07:00 am

More quotes
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas: - sale of drugs and consumer care products; - services. Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,298 JPY
Average target price
4,744 JPY
Spread / Average Target
+10.39%
Consensus